These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25176471)

  • 1. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantation.
    Kim MK; Choi HJ; Kwon I; Pierson RN; Cooper DK; Soulillou JP; O'Connell PJ; Vabres B; Maeda N; Hara H; Scobie L; Gianello P; Takeuchi Y; Yamada K; Hwang ES; Kim SJ; Park CG;
    Xenotransplantation; 2014; 21(5):420-30. PubMed ID: 25176471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical and regulatory guidelines in clinical trials of xenocorneal transplantation in Korea; the Korean xenocorneal transplantation consensus statement.
    Kim MK; Lee JJ; Choi HJ; Kwon I; Lee H; Song JS; Kim MJ; Chung ES; Wee WR; Park CG; Kim SJ; ;
    Xenotransplantation; 2013; 20(4):209-18. PubMed ID: 23683073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 1: Key ethical requirements and progress toward the definition of an international regulatory framework.
    Cozzi E; Tallacchini M; Flanagan EB; Pierson RN; Sykes M; Vanderpool HY
    Xenotransplantation; 2009; 16(4):203-14. PubMed ID: 19799760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Executive summary.
    Hering BJ; Cozzi E; Spizzo T; Cowan PJ; Rayat GR; Cooper DK; Denner J
    Xenotransplantation; 2016; 23(1):3-13. PubMed ID: 26940725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-- executive summary.
    Hering BJ; Cooper DK; Cozzi E; Schuurman HJ; Korbutt GS; Denner J; O'Connell PJ; Vanderpool HY; Pierson RN
    Xenotransplantation; 2009; 16(4):196-202. PubMed ID: 19799759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
    Vanderpool HY
    Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 1: update on national regulatory frameworks pertinent to clinical islet xenotransplantation.
    Cozzi E; Tönjes RR; Gianello P; Bühler LH; Rayat GR; Matsumoto S; Park CG; Kwon I; Wang W; O'Connell P; Jessamine S; Elliott RB; Kobayashi T; Hering BJ
    Xenotransplantation; 2016; 23(1):14-24. PubMed ID: 26940509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 3: Porcine islet product manufacturing and release testing criteria.
    Rayat GR; Gazda LS; Hawthorne WJ; Hering BJ; Hosking P; Matsumoto S; Rajotte RV
    Xenotransplantation; 2016; 23(1):38-45. PubMed ID: 26923763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for the first clinical trial to investigate safety and efficacy of corneal xenotransplantation in patients with corneal opacity, corneal perforation, or impending corneal perforation.
    Choi HJ; Yoon CH; Hyon JY; Lee HK; Song JS; Chung TY; Mo H; Kim J; Kim JE; Hahm BJ; Yang J; Park WB; Kim MK
    Xenotransplantation; 2019 Jan; 26(1):e12446. PubMed ID: 30063072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of corneal xenotransplantation.
    Kim MK; Hara H
    Int J Surg; 2015 Nov; 23(Pt B):255-260. PubMed ID: 26231995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 6: Patient selection for pilot clinical trials of islet xenotransplantation.
    O'Connell PJ
    Xenotransplantation; 2009; 16(4):249-54. PubMed ID: 19799765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The attitude toward xenocorneal transplantation in wait-listed subjects for corneal transplantation in Korea.
    Lee JJ; Kim DH; Jang YE; Choi HJ; Kim MK; Wee WR
    Xenotransplantation; 2014; 21(1):25-34. PubMed ID: 24164549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysico-functional compatibility of Seoul National University (SNU) miniature pig cornea as xenocorneal graft for the use of human clinical trial.
    Kim DH; Kim J; Jeong HJ; Lee HJ; Kim MK; Wee WR
    Xenotransplantation; 2016 May; 23(3):202-10. PubMed ID: 27170205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 4: pre-clinical efficacy and complication data required to justify a clinical trial.
    Cooper DK; Bottino R; Gianello P; Graham M; Hawthorne WJ; Kirk AD; Korsgren O; Park CG; Weber C
    Xenotransplantation; 2016; 23(1):46-52. PubMed ID: 26916706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 2a: source pigs--preventing xenozoonoses.
    Spizzo T; Denner J; Gazda L; Martin M; Nathu D; Scobie L; Takeuchi Y
    Xenotransplantation; 2016; 23(1):25-31. PubMed ID: 26940608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal Xenotransplantation: Anterior Lamellar Keratoplasty.
    Vabres B; Vanhove B; Blancho G
    Methods Mol Biol; 2020; 2110():245-251. PubMed ID: 32002913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotransplantation.
    Hering BJ; O'Connell PJ
    Xenotransplantation; 2016; 23(1):60-76. PubMed ID: 26918540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Clinical Xenotransplantation: A Reappraisal of the Legal, Ethical, and Social Aspects Involved.
    Jorqui-Azofra M
    Methods Mol Biol; 2020; 2110():315-358. PubMed ID: 32002917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Justifying clinical trials for porcine islet xenotransplantation.
    Ellis CE; Korbutt GS
    Xenotransplantation; 2015; 22(5):336-44. PubMed ID: 26381492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Cardiac Xenotransplantation: Recommendations for the Ethical Design of Clinical Trials.
    Hurst DJ; Padilla L; Merlocco A; Rodger D; Bobier C; Gray WH; Sorabella R; Cooper DKC; Pierson RN
    Transplantation; 2024 Oct; 108(10):e292-e300. PubMed ID: 38419158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.